IGIM
PDLI

I.G. Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History

I.G. Investment Management’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,290,100
Closed -$7.67M – 872
2016
Q3 		$7.67M Buy
2,290,100
+52,900
+2% +$168K 0.03% 311
2016
Q2 		$7.03M Buy
2,237,200
+89,200
+4% +$297K 0.03% 319
2016
Q1 		$7.15M Buy
2,148,000
+156,000
+8% +$486K 0.03% 309
2015
Q4 		$7.05M Buy
+1,992,000
New +$8.34M 0.03% 290

Other funds holding PDLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

I.G. Investment Management's PDLI Position: Q4 2016 in Review

I.G. Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q4 2016, closing a stake of 2,290,100 shares — an estimated $7.67M sold.

I.G. Investment Management first reported a position in PDLI in Q4 2015 and held it in 4 quarters. The position peaked at $7.67M in Q3 2016. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

  • I.G. Investment Management reported no remaining PDL BioPharma, Inc. position as of Q4 2016 after selling out during the quarter.
  • I.G. Investment Management sold 2,290,100 PDL BioPharma, Inc. shares in Q4 2016, an estimated $7.67M.
  • I.G. Investment Management first reported a position in PDL BioPharma, Inc. in Q4 2015 and held it in 4 quarters.
  • I.G. Investment Management's PDL BioPharma, Inc. position peaked at $7.67M in Q3 2016.
  • 190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on I.G. Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.